-
Product Insights
Likelihood of Approval Analysis for Age Related Macular Degeneration
Overview How likely is it that the drugs in Age Related Macular Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Age Related Macular Degeneration Overview Macular degeneration, also known as...
-
Product Insights
Likelihood of Approval Analysis for Diabetic Retinopathy
Overview How likely is it that the drugs in Diabetic Retinopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Retinopathy Overview Diabetic retinopathy is a complication of diabetes that affects...
-
Product Insights
Likelihood of Approval Analysis for Glaucoma
Overview How likely is it that the drugs in Glaucoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Glaucoma Overview Glaucoma is a disease of the eye in which fluid pressure...
-
Product Insights
Likelihood of Approval Analysis for Intermediate Uveitis
Overview How likely is it that the drugs in Intermediate Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Intermediate Uveitis Overview Intermediate uveitis is a type of uveitis, which is...
-
Product Insights
Likelihood of Approval Analysis for Macular Edema
Overview How likely is it that the drugs in Macular Edema will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Macular Edema Overview Macular edema is swelling or fluid retention in a...
-
Product Insights
Likelihood of Approval Analysis for Uveitis
Overview How likely is it that the drugs in Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Uveitis Overview Uveitis is swelling and irritation of the uvea, the middle layer...
-
Product Insights
Likelihood of Approval Analysis for Vision Disorders
Overview How likely is it that the drugs in Vision Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vision Disorders Overview Vision disorders are characterized by poor or unclear vision...
-
Product Insights
Likelihood of Approval Analysis for Proliferative Diabetic Retinopathy (PDR)
Overview How likely is it that the drugs in Proliferative Diabetic Retinopathy (PDR) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Proliferative Diabetic Retinopathy (PDR) Overview Proliferative diabetic retinopathy (PDR) is...
-
Product Insights
Likelihood of Approval Analysis for Ocular Pain (Eye Pain)
Overview How likely is it that the drugs in Ocular Pain (Eye Pain) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ocular Pain (Eye Pain) Overview Ocular pain, commonly known as...
-
Product Insights
Likelihood of Approval Analysis for Metastatic Uveal Melanoma
Overview How likely is it that the drugs in Metastatic Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Uveal Melanoma Overview Metastatic uveal melanoma is a rare and...